[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100533926":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":33,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":7,"maxAge":44,"enrollmentInfo":45,"targetDuration":48,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":55,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Mohammed Gamil, Professor","STUDY_DIRECTOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Marina Farah Fawzy Gad, Master","CONTACT","01069928577","m_marina70@yahoo.com",[19],{"facility":5,"status":7,"city":20,"state":7,"zip":7,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Asyut","Egypt","EG",{"type":24,"coordinates":25},"Point",[26,27],31.18368,27.18096,{"lat":27,"lon":26},[30],{"name":31,"role":32,"phone":7,"phoneExt":7,"email":7},"marina farah fawzy, master","PRINCIPAL_INVESTIGATOR",{"type":32,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"marina farah fawzy gad","Pediatric resident","100533926","value-of-transcutaneous-bilirubin-devices-100533926",false,"NCT06232174","Value of Transcutaneous Bilirubin Devices","Study of the Value of Transcutaneous Bilirubin Devices in Jaundiced Newborns at Assiut University Children's Hospital","Inclusion Criteria:\n\n* They were born between 35 and 42 weeks of gestation, had a birth weight of more than 2 kg, and were aged between 0 days and 28 days\n\nExclusion Criteria:\n\n* Exclusion criteria are severely ill neonates, neonates with a lethal congenital malformation, and or had skin disease, had received phototherapy before, and received exchange transfusion.","ALL","28 Days",{"count":46,"type":47},80,"ESTIMATED","25 Days","OBSERVATIONAL","The goal of this observational study is to compare the value of transcutaneous bilirubin devices versus serum bilirubin in jaundiced neonates",[52],"Jaundice",[54],"Neonatal jaundice","NOT_YET_RECRUITING","2024-07-29",{"date":58,"type":59},"2024-07-30","ACTUAL",{"date":61,"type":47},"2024-08",{"date":63,"type":47},"2025-03",{"name":5,"class":6},1]